Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects
NCT04341077 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2020-04-10
Summary
Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects
Conditions
- Healthy Adult Male and Female Volunteers
Interventions
- DRUG
-
SHR3162
A single oral dose of fluzoparib on Day 1
Sponsors & Collaborators
-
Jiangsu HengRui Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-10
- Primary Completion
- 2020-04-20
- Completion
- 2020-10-20
More Related Trials
-
A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERS
NCT02749097 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Bioavailability of SHR0302 in Healthy Subjects
NCT04712838 ·Status: COMPLETED ·Phase: PHASE1
-
The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects
NCT03870100 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults
NCT07235137 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects
NCT06995001 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects
NCT04793204 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers
NCT05354336 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese Participants
NCT03959332 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375
NCT05026008 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy Volunteers
NCT06932536 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects
NCT05404724 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers
NCT05753033 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)
NCT05058118 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.
NCT03530917 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers
NCT05012761 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects
NCT04512170 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers
NCT05421923 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
NCT04527718 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers
NCT04021563 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061
NCT07241910 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of NBL-012 in Healthy Chinese Subjects
NCT05259189 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.
NCT04958291 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women
NCT05930704 ·Status: UNKNOWN ·Phase: PHASE1
-
A Trial of SHR-1819 in Healthy Subjects
NCT04561128 ·Status: COMPLETED ·Phase: PHASE1